Skip to main content
. 2023 Dec 1;42(1):35–43. doi: 10.1007/s10637-023-01416-w

Table 2.

Efficacy endpoints and measures of best response

Best response using RECIST criteria
Response All patients (n = 8)
n (%)
Complete Response 0 (0%)
Partial Response 1 (12.5%)
Stable Disease 3 (37.5%)
Progressive Disease 4 (50%)
Disease control rate 50%